Eloxx Pharmaceuticals, Inc (ELOX)

CIK 1035354 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Eloxx Pharmaceuticals, Inc.

Recent SEC filings

FiledFormAccession number
Oct 22, 2026424B30001193125-26-428120
Oct 22, 20268-K0001193125-26-428116
Oct 21, 202630001193125-26-428118
Oct 21, 202640001193125-26-428121
Sep 18, 2026EFFECT9999999995-26-003014
Sep 11, 2026S-10001193125-26-389422
Aug 14, 2026SCHEDULE 13G0001104659-26-097268
Aug 14, 2026SCHEDULE 13G0001699737-26-000018
Aug 11, 20268-K0001193125-26-345032
Aug 11, 202610-Q0001193125-26-344964
Jul 27, 2026SCHEDULE 13G0001716774-26-000020
Jun 17, 2026SCHEDULE 13G0001104659-26-075290
Jun 17, 2026SCHEDULE 13G0000919574-26-004022
Jun 17, 202630000919574-26-004020
Jun 17, 202640000919574-26-004021
Jun 16, 2026SCHEDULE 13G0000935836-26-000321
Jun 16, 2026SCHEDULE 13G0001440771-26-000006
Jun 15, 2026SCHEDULE 13G0002005369-26-000037
Jun 10, 202640001193125-26-266278
Jun 10, 202640001193125-26-266275
Jun 10, 202640001193125-26-266276
Jun 10, 202640001193125-26-266277
Jun 10, 202640001193125-26-266279
Jun 9, 2026424B40001193125-26-263914
Jun 8, 2026EFFECT9999999995-26-001918